Concepedia

Dissolution-limited Interactions

Dissolution-Limited Interactions is a type of drug-drug interaction in which the reduction in the rate or extent of absorption of a drug occurs due to altered dissolution characteristics of the drug in the gastrointestinal tract, primarily caused by concomitant administration of another agent affecting the local pH, solubility, or precipitating conditions.

4

Publications

330

Citations

31

Authors

5

Institutions

Publications per year

2017–2026

0

Parents

Publications

4

Discovery of 4-Benzoyl-1-[(4-methoxy-1<i>H</i>- pyrrolo[2,3-<i>b</i>]pyridin-3-yl)oxoacetyl]-2- (<i>R</i>)-methylpiperazine (BMS-378806):  A Novel HIV-1 Attachment Inhibitor That Interferes with CD4-gp120 Interactions

Tao Wang, Zhongxing Zhang, Owen B. Wallace et al. · Journal of Medicinal Chemistry · 2003 · 206 citations

, , +17

In vitro Studies on the Potential for Pulpal Cytotoxicity of Glass-Ionomer Cements

G. J. Mount · Journal of Dental Research · 1988 · 93 citations

, , +14

Hydrodynamic Effects on Drug Dissolution and Deaggregation in the Small Intestine—A Study with Felodipine as a Model Drug

Lennart Lindfors, Malin K.B. Jonsson, Emelie Weibull et al. · Journal of Pharmaceutical Sciences · 2015 · 20 citations · Full text

, , +17

Limit Behavior of Pair Formation for a Large Dissolution Rate

Xiaolong Luo, Carlos Castillo‐Chávez · eCommons (Cornell University) · 1992 · 11 citations · Full text

, , +10

Physiologically relevant dissolution conditions towards improved in vitro - in vivo relationship – A case study with enteric coated pantoprazole tablets

Daniela Amaral Silva, Marcelo Gomes Davanço, Neal M. Davies et al. · International Journal of Pharmaceutics · 2021 · 10 citations

, , +17

1–5 of 4

Authors

31

  1. LZ
    Lisa Zadjura

    Bristol-Myers Squibb (United States), United States

    1 publications · 206 citations

    1

    h-index

  2. EW
    Emelie Weibull

    Pennsylvania State University, United States

    1 publications · 20 citations

    1

    h-index

  3. GJ
    G. J. Mount

    The University of Adelaide, Australia

    1 publications · 93 citations

    1

    h-index

  4. KR
    Keith Ricarrdi

    Bristol-Myers Squibb (Germany), Germany

    1 publications · 206 citations

    1

    h-index

  5. SA
    Sunanda A. Ranadive

    Bristol-Myers Squibb (United States), United States

    1 publications · 206 citations

    1

    h-index

1–5 of 31

Institutions

5

  1. Bristol-Myers Squibb (United States)

    New York, United States

    1 h-index

    23 publications

    4.7K citations

  2. The University of Adelaide

    Adelaide, Australia

    1 h-index

    2 publications

    186 citations

  3. AstraZeneca (Sweden)

    Södertälje, Sweden

    1 h-index

    4 publications

    80 citations

  4. Bristol-Myers Squibb (Germany)

    Munich, Germany

    1 h-index

    22 publications

    4.5K citations

  5. Pennsylvania State University

    State College, United States

    1 h-index

    1 publications

    20 citations

  6. University of Alberta

    Edmonton, Canada

    1 publications

    10 citations

  7. Universidade São Francisco

    Bragança Paulista, Brazil

    1 publications

    10 citations

1–7 of 5

Venues

  1. eCommons (Cornell University)

    Repository · 1 publications · 11 citations

    1

    h-index

  2. Journal of Medicinal Chemistry

    1 publications · 206 citations

    1

    h-index

  3. Journal of Pharmaceutical Sciences

    1 publications · 20 citations

    1

    h-index

  4. Journal of Dental Research

    JDR · 1 publications · 93 citations

    1

    h-index

  5. International Journal of Pharmaceutics

    1 publications · 10 citations

1–5